Should you buy Astera Labs stock now?
The technical signal for Astera Labs is currently NEUTRAL. Astera Labs trades at $336.14 as of 8/6/2026. The overall technical signal is: Hold. The technical analysis shows the following: MACD is negative (bearish trend) at -13.162 with rising momentum (signal: -16.051); RSI is at 47.8 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $317.92 is 5.4% below the current price. This is a technical observation based on current data, not investment advice.
What is the price target for Astera Labs stock?
The average analyst price target for Astera Labs is $317.92. The current price is $336.14, which gives a downside of 5.4%. Based on this, the stock is considered fairly valued. The fair value range (±10% of the price target) is between $286.13 and $349.71.
Is Astera Labs a dividend stock?
No, Astera Labs does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Astera Labs stock?
Astera Labs is rated as a stock with extreme risk. the annual standard deviation is 98.1%, which classifies the stock as extreme risk.
Is Astera Labs overvalued?
Astera Labs is considered fairly valued – the price is close to the analyst price target. Astera Labs has the following valuation ratios: a P/E ratio of 244.4 (highly valued), a P/S ratio of 61.9, a P/B ratio of 35.7. The stock trades close to the analyst price target and is considered fairly valued.
Is Astera Labs overbought?
No, Astera Labs is not overbought. RSI is at 47.8 (neutral zone). The technical indicators show: RSI is at 47.8 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 3.3% above the 20-day average (short-term uptrend). In addition, MACD is negative, but momentum is rising (possible trend reversal).
When is the next Astera Labs earnings report?
The date of the next earnings report for Astera Labs has not been published yet. Check the company's investor calendar for updates.
Is Astera Labs shorted?
Yes, Astera Labs is shorted with 7.3% of the free float sold short. This is a high level of short selling, which suggests some investors are betting on falling prices. Positive surprises can lead to a moderate short squeeze. Data is updated daily based on official filings with the SEC.
Are insiders buying Astera Labs stock?
No, insiders are not buying Astera Labs shares – they are net sellers. Over the last 3 months, insiders have made 1 purchases and 12 sales. On a net basis, 88,863,369 $ worth of shares were sold. Across the last 20 reported transactions, the split is 1 purchases and 19 sales, with a net 111,773,633 $ sold. Active sellers include Dyckerhoff Stefan A, ALBA MANUEL, Mayer Bethany and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Astera Labs a good stock?
Based on our total score, Astera Labs is rated as a mediocre stock with a total score of 40 out of 100. The stock scores around average on value, quality and momentum – it sits near the median in our database. The score is made up of Value: 4/100, Quality: 74/100, Momentum: 43/100. In addition: technical signal: Hold. Whether Astera Labs is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Astera Labs stock?
The outlook for Astera Labs based on current data: the average analyst price target is $317.92 (-5.4%); the P/E ratio is 244.4 (high – the market expects growth). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Astera Labs stock rising?
Astera Labs is rising right now. The technical indicators show: the price is 3.3% above the 20-day average; short interest is 7.3% (high – many are betting on a decline); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can Astera Labs go?
The average analyst price target for Astera Labs is $317.92, which is 5.4% below the current price of $336.14. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Astera Labs fall?
We lack enough history to give a specific floor for Astera Labs. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Astera Labs do?
Astera Labs, Inc. designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying so... The company belongs to the Teknologi sector, more specifically the Semiconductors industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Astera Labs as an investment.
Did Astera Labs raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Astera Labs. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is Astera Labs making money or losing money?
Yes, Astera Labs is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 26.7% — which is excellent. The operating margin (profit before interest and taxes) is 20.1%. At a P/E ratio of 244.4, you currently pay 244.4 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can Astera Labs go bankrupt?
The bankruptcy risk of Astera Labs is rated as low. Altman Z2 (a model for assessing financial distress) is 15.85 — that places the company in the healthy zone. The company has a healthy balance sheet with limited debt relative to earnings and assets. The Piotroski score (financial health 0-9, higher is better) is 6 — which is average. Debt relative to equity is 9% (low). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Astera Labs have a lot of debt?
No, Astera Labs has low debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 9%. For the teknologi sector, anything below 80% counts as low debt. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector.
